Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

JC virus Reactivation During Prolonged Natalizumab Monotherapy for Multiple Sclerosis.
Experiences of functional electrical stimulation (FES) and ankle foot orthoses (AFOs) for foot-drop in people with multiple sclerosis.
The role of diet in multiple sclerosis.
Differentiation of neurosphere-derived rat neural stem cells into oligodendrocyte-like cells by repressing PDGF-α and Olig2 with triiodothyronine.
The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer.
A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients.
Behçet's disease patients with multiple sclerosis-like features: discriminative value of Barkhof criteria.
Early recognition and diagnosis of multiple sclerosis.
FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation.
Similar autobiographical memory impairment in long-term secondary progressive multiple sclerosis and Alzheimer's disease.
Neuropsychiatric symptoms as a manifestation of multiple sclerosis after 2-year follow-up period.
UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production.
Improved clinical behavior of established relapsing-remitting experimental autoimmune encephalomyelitis following treatment with endogenous opioids: Implications for the treatment of multiple sclerosis.
Reduced sick leave in multiple sclerosis after one year of natalizumab treatment. A prospective ad hoc analysis of the TYNERGY trial.
Reverse causality behind the association between reproductive history and MS.
Co-occurrence of two cases of progressive multifocal leukoencephalopathy in a natalizumab "infusion group"
The Impact of a Patient Support Program for Multiple Sclerosis on Patient Satisfaction and Subjective Health Status.
Consequences of NMO-IgG binding to aquaporin-4 in neuromyelitis optica.
Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: subgroup analysis of the natalizumab observational program.
Evaluating cognitive rehabilitation in multiple sclerosis: on the bumpy road to establishing evidence.
Fingolimod targeting protein phosphatase 2A differently affects IL-33 induced IL-2 and IFN-γ production in CD8(+) lymphocytes.
Remyelination after Lysophosphatidyl Choline-Induced Demyelination Is Stimulated by Bone Marrow Stromal Cell-Derived Oligoprogenitor Cell Transplantation.
Insights into TREM2 biology by network analysis of human brain gene expression data.
Schwann cells in therapy of spinal cord injuries.
Merck Serono and Opexa Therapeutics Enter into Option and License Agreement for Development of Tcelna™ (imilecleucel-T) for Treatment of Multiple Sclerosis

Pages